Skip to content
Search

Latest Stories

Keith Ridge praises pharmacy technicians for their selfless service during pandemic

Chief pharmaceutical officer for England Dr Keith Ridge has praised pharmacy technicians across all parts of the NHS for their selfless service during the current pandemic.

Coinciding with the World Pharmacy Technicians Day, Dr Ridge published an open letter on October 20 in which he thanked pharmacy technicians for “their incredible contribution to and support for excellent patient care throughout the Covid-19 pandemic so far.”


In the letter addressed to Liz Fidler, president of the Association of Pharmacy Technicians UK (APTUK), he wrote: “I have been impressed by the many examples of leadership, delivery and sheer fortitude that have been shown by pharmacy technician colleagues across all parts of the NHS and these are deserving of great praise.”

Dr Ridge highlighted that the profession has a "great future ahead", nothing that the "NHS Long Term Plan identifies a strong and growing role for the pharmacy team across the

NHS which won’t be achievable without the appropriate clinical deployment of

pharmacy technicians."

He emphasised that their role was critical to the functioning of the pharmacy team and pharmacy and medicines optimisation services in the NHS.

"The professional contribution of pharmacy technicians during the pandemic further confirms that this is the right approach," he noted.

While thanking "the impressive leadership and contribution of the APTUK" he outlined several new initiatives the NHS has undertaken to consolidate the roles of pharmacy technicians, such as:

• The inclusion of the pharmacy technician role in the Additional Roles Reimbursement Scheme so that primary care networks are able to recruit pharmacy technicians into general practices meaning there will be hundreds more in post in the next four years.

• The inclusion of pharmacy technicians in the Primary Care Pharmacy Education Pathway.

• The expansion of training places and the piloting of the Pre-Registration Trainee Pharmacy Technician role, in a system approach including primary care.

• The publication of the National Competency Framework for Primary Care Pharmacy Technicians.

• A national framework procurement process to facilitate access to apprenticeship funding to train pharmacy technicians in all settings.

He stressed the need for developing "a sustainable approach that will be beneficial to pharmacy technicians in terms of career progression and professional development."

He however added that this would mean mean increasing recruitment, maximising the potential of the clinical role of pharmacy technicians in the NHS, increasing the numbers of those seeking professional registration and ensuring support for APTUK as the professional body.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less